Edwards Lifesciences Corp (NYSE:EW)
| 67.82 Delayed Data As of Jul 10 |  -0.44 / -0.64%Today’s Change | 51.51 Today|||52-Week Range 82.55 | -12.79% Year-to-Date |
Latest EW News | Press Releases
No recent news for Edwards Lifesciences Corp.
Today’s Trading
| Previous close | 68.26 |
| Today’s open | 68.40 |
| Day’s range | 66.87 - 68.40 |
| Volume | 2,799,882 |
| Average volume (3 months) | 4,213,220 |
| Market cap | $42.9B |
Data as of 4:57pm ET, 07/10/2020
Growth & Valuation
| Earnings growth (last year) | +45.68% |
| Earnings growth (this year) | -11.47% |
| Earnings growth (next 5 years) | +11.90% |
| Revenue growth (last year) | +16.79% |
| P/E ratio | 39.0 |
| Price/Sales | 11.39 |
| Price/Book | 10.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SYKStryker Corp | +0.18 | +0.10% |
| ISRGIntuitive Surgical | +1.81 | +0.32% |
| SNNSmith & Nephew PLC | +0.07 | +0.18% |
| STESteris plc | +0.11 | +0.07% |
Data as of 4:00pm ET, 07/10/2020
Financials
| Next reporting date | July 24, 2020 |
| EPS forecast (this quarter) | $0.18 |
| Annual revenue (last year) | $4.3B |
| Annual profit (last year) | $1.0B |
| Net profit margin | 24.08% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
